Andisheh has been a Contract Research Organization (CRO) since it was funded in 2015. This includes:
- Contract Synthesis and Production of Various Chemical Entities: including, but not limited to, Category I – V active pharmaceuticals ingredients (APIs), Secondary Reference Standards, Category I – V drug products, excipients, antibody drug conjugates, organic building blocks (OBBs) for the production of API intermediates with complete technology transfer (lab, scale-up, pilot)
- Synthesis of Secondary Reference Standards approved by the Ministry of Health: for available SRS see our catalogue (download). For other please contact our sales department:
email: Sales01@Andishehct.com
phone: 8849 7298, 0922 268 9092 - Contract Research for Process Development of Category I – V APIs: as per client’s specifications with complete technology transfer (lab, scale-up, pilot)
- Contract Research for Process Development of Category I – V Oral Solid Drug Products: as per client’s specifications with complete technology transfer (lab, scale-up, pilot)
- Contract Synthesis and Production of New Chemical Entities for Clinical Trials: as per client’s specifications
- Contract Isolation of Enantiomers on Industrial Scale: using our proprietary methods and based of client’s specifications with complete technology transfer (lab, scale-up, pilot) (ACS Omega 2017, 2, 8717−8722; US Patent Application 2019/0211150A1, July 11, 2019)`
- Contact Synthesis and Production of Antibody-Drug Conjugates: using our proprietary methods with complete technology transfer (lab, scale-up, pilot)and based of client’s specifications as per client’s specifications(ACS Omega , ACS Omega, 2021, doi: 10.1021/acsomega.0c06149; US Patent Application 2022/0411463 A1, December 29, 2022)
- Contract Downstream Process Development for facilitated Isolation of mAbs: as per our proprietary process with complete technology transfer (lab, scale-up, pilot) (ACS Omega , ACS Omega, 2021, doi: 10.1021/acsomega.0c06149; US Patent Application 2022/0411463 A1, December 29, 2022)
- Contract Research for new and Improved formulation of Drugs in various Formats: oral solid dosage, injectables, creams, suppositories and syrups with complete technology transfer (lab, scale-up, pilot)
